Page last updated: 2024-11-12

morroniside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

morroniside: from Cornus officinalis; protects cultured human umbilical vein endothelial cells from damage by high ambient glucose; a component of cornel iridoid glycoside; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CornusgenusA plant genus of the family CORNACEAE. It is widely cultivated for the attractive flowers.[MeSH]CornaceaeA plant family of the order Cornales, subclass Rosidae, class Magnoliopsida that is a loose grouping of woody ornamentals: 11 of its 14 genera have been placed in single families by some authorities. Some botanists combine members of NYSSACEAE into this family.[MeSH]

Cross-References

ID SourceID
PubMed CID102004523
MeSH IDM0470536

Synonyms (3)

Synonym
morroniside
25406-64-8
AKOS037514746

Research Excerpts

Pharmacokinetics

The pharmacokinetic behavior of morroniside and loganin in normal and CKD rat plasma was determined in this paper. Back-propagation (BP) neural network method was fist developed for the prediction of pharmacokinetics (PK) parameters of morronside in Fructus Corni.

ExcerptReferenceRelevance
" An HPLC method for determination of morroniside in rat plasma and tissues was developed and the pharmacokinetic and tissue distribution characteristics of morroniside after intravenous and oral administrations were investigated."( HPLC study of pharmacokinetics and tissue distribution of morroniside in rats.
Jing, X; Li, D; Li, M; Li, X; Sheng, X; Wang, Q; Zhang, L; Zhang, X; Zhou, Y, 2007
)
0.34
"In this article, back-propagation (BP) neural network method was fist developed for the prediction of pharmacokinetic (PK) parameters of morroniside in Fructus Corni."( Pharmacokinetic parameters of morroniside in iridoid glycosides of Fructus corni processing based on back-propagation neural network.
Cai, B; Cai, H; Cao, G; Cong, X; Shan, Q; Zhang, C; Zhang, Y, 2011
)
0.37
" The renal impairment may affect drug clearance and other pharmacokinetic processes which can increase toxicity and drug to drug interactions or cause ineffective therapy."( Comparative pharmacokinetics of the main compounds of Shanzhuyu extract after oral administration in normal and chronic kidney disease rats.
Du, L; Duan, JA; Guo, J; Jiang, S; Liu, P; Qian, D; Shang, EX; Su, SL; Tao, J; Zhao, M, 2015
)
0.42
"The pharmacokinetic behavior of morroniside and loganin in normal and CKD rat plasma was determined in this paper."( Comparative pharmacokinetics of the main compounds of Shanzhuyu extract after oral administration in normal and chronic kidney disease rats.
Du, L; Duan, JA; Guo, J; Jiang, S; Liu, P; Qian, D; Shang, EX; Su, SL; Tao, J; Zhao, M, 2015
)
0.42
" The method was successfully applied to pharmacokinetic study of the analytes in normal and doxorubicin-induced chronic kidney disease rat plasma."( Simultaneous determination of loganin, morroniside, catalpol and acteoside in normal and chronic kidney disease rat plasma by UPLC-MS for investigating the pharmacokinetics of Rehmannia glutinosa and Cornus officinalis Sieb drug pair extract.
Du, L; Duan, JA; Guo, J; Jiang, S; Liu, P; Qian, D; Shang, EX; Su, SL; Tao, J; Zhao, M, 2016
)
0.43

Bioavailability

Morroniside was absorbed and eliminated rapidly in rat. It manifested linear dynamics at 10-40 mg/kg range. absolute bioavailability of morron iside was lower.

ExcerptReferenceRelevance
" Pharmacokinetic study found that morroniside was absorbed and eliminated rapidly in rat and manifested linear dynamics at 10-40 mg/kg range and absolute bioavailability of morroniside was lower."( HPLC study of pharmacokinetics and tissue distribution of morroniside in rats.
Jing, X; Li, D; Li, M; Li, X; Sheng, X; Wang, Q; Zhang, L; Zhang, X; Zhou, Y, 2007
)
0.34
" After treatment with morroniside, the activity, mRNA and protein expression of CYP3A were significantly induced and the absorbance and bioavailability of midazolam in rats were reduced."( Induction of CYP3A by morroniside in rats.
Li, J; Wang, X; Xiong, S; Zhang, W; Zhang, Z, 2015
)
0.42
" In the present study, the pharmacokinetics and bioavailability studies of morroniside were conducted on Sprague-Dawley (SD) rats."( The absorption of oral morroniside in rats: In vivo, in situ and in vitro studies.
Li, J; Mu, Y; Xiong, S; Zhang, Z, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (20.25)29.6817
2010's39 (49.37)24.3611
2020's24 (30.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]